Part 1, Reference for Chapter 14: Clinical Pharmacology
Skip chapter table of contents and go to main content
- 1 Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329(7456):15–9. Cross Ref link Pubmed link , , , et al.
- 2 Incidence of adverse drug reactions in hospitalized patients: a meta‐analysis of prospective studies. JAMA 1998;279(15):1200–5. Cross Ref link Pubmed link , , .
- 3 Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63(2):136–47. Cross Ref link Pubmed link , , , et al.
- 4 Frequency of and risk factors for preventable medication‐related hospital admissions in the netherlands. Arch Intern Med 2008;168(17):1890–6. Pubmed link , , , , .
- 5 Co‐ordination Group for Mutual Recognition and Decentralised Procedures – Human. CMDh Questions and Answers: Biologicals. 2012. http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Questions_Answers/CMDh_269_2012_Rev0_2012_10.pdf (last accessed January 2015).
- 6 Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism and elimination. In: Brunton LL, Chabner BA, Knollman BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th edn. New York: McGraw Hill Medical, 2011:17–40. , .
- 7 Pharmacokinetic aspects of biotechnology products. J Pharm Sci 2004;93(9):2184–204. Cross Ref link Pubmed link , , , .
- 8 Pharmacokinetics and toxicology of therapeutic proteins: advances and challenges. World J Biol Chem 2012;3(4):73–92. Cross Ref link Pubmed link , , , , .
- 9 Pharmacokinetics, pharmacodynamics and physiologically‐based pharmacokinetic modelling of monoclonal antibodies. Clin Pharmacokinet 2013;52(2):83–124. Cross Ref link Pubmed link , , , , .
- 10 Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 2008;84(5):548–58. Cross Ref link Pubmed link , , .
- 11 Transdermal drug delivery. Nature Biotech 2008;26:1261–9. Cross Ref link , .
- 12 Synthetic therapeutic peptides: science and market. Drug Discov Today 2010;15(1–2):40–56. Cross Ref link Pubmed link , , , .
- 13 Orally active‐targeted drug delivery systems for proteins and peptides. Expert Opin Drug Deliv 11(9):1435–47. Cross Ref link Pubmed link , , , , , .
- 14 Target‐mediated drug disposition and dynamics. Biochem Pharmacol 2006;72(1):1–10. Cross Ref link Pubmed link .
- 15 Elimination mechanisms of therapeutic monoclonal antibodies. Drug Discov Today 2006;11(1–2):81–8. Cross Ref link Pubmed link , , .
- 16 Pharmacodynamics: molecular mechanisms of drug action. In: Brunton LL, Chabner BA, Knollman BC, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 12th edn. New York: McGraw Hill Medicine, 2011:41–72. , .
- 17 Developmental pharmacology – drug disposition, action, and therapy in infants and children. N Eng J Med 2003;349(12):1157–67. Cross Ref link , , , , , .
- 18 Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 2009;41(2):67–76. Cross Ref link Pubmed link .
- 19 Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56(2):163–84. Cross Ref link Pubmed link , .
- 20 Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289(9):1107–16. Cross Ref link Pubmed link , , , et al.
- 21 Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009;338:a2752. Cross Ref link Pubmed link , , , , , .
- 22 Neurobehavioral teratology of isotretinoin. Reprod Toxicol 1993;7(2):175–7. Cross Ref link Pubmed link , .
- 23 Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population‐based cohort study. JAMA Dermatol 2013;149(11):1274–80. Cross Ref link Pubmed link , , , .
- 24 Pharmacometrics in pregnancy: an unmet need. Ann Rev Pharmacol Toxicol 2014;54(1):53–69. Cross Ref link , , , .
- 25 Biologic therapies and pregnancy: the story so far. Rheumatology 2014;53(8):1377–85. Cross Ref link Pubmed link , .
- 26 The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception. Aliment Pharmacol Ther 2004;19(6):679–85. Cross Ref link Pubmed link , , , , .
- 27 No evidence for an increased risk of adverse pregnancy outcome after paternal low‐dose methotrexate: an observational cohort study. Rheumatology 2014;53(4):757–63. Cross Ref link Pubmed link , , , , .
- 28 New era in drug interaction evaluation: us food and drug administration update on cyp enzymes, transporters, and the guidance process. J Clin Pharmacol 2008;48(6):662–70. Cross Ref link Pubmed link , , , , , , et al.
- 29 The effect of echinacea (Echinacea purpurea root) on cytochrome p450 activity in vivo. Clin Pharmacol Ther 2004;75(1):89–100. Cross Ref link Pubmed link , , , et al.
- 30 The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers. Br J Clin Pharmacol 2008;65(5):693–700. Cross Ref link Pubmed link , , , .
- 31 Therapeutic protein–drug interactions and implications for drug development. Clin Pharmacol Ther 2010;87(4):497–503. Cross Ref link Pubmed link , , , et al.
- 32 National Institute for Health and Care Excellence. Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence. 2009. http://guidance.nice.org.uk/CG76/NiceGuidance/pdf/English (last accessed January 2015).
- 33 Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008;Issue 2:CD000011. Pubmed link , , , , .
- 34 Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007;41(9):15. Cross Ref link , , , , .
- 35 Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002;359(9315):1373–8. Cross Ref link Pubmed link , , , .
- 36 Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Safety Health Care 2009;18(1):22–7. Cross Ref link , , , et al.
- 37 Interventions to reduce pediatric medication errors: a systematic review. Pediatrics 2014;134(2):338–60. Cross Ref link Pubmed link , , , et al.
- 38 The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta‐analysis. Syst Rev 2014;3(56):12. Cross Ref link Pubmed link , , , et al.
- 39 Personalized pharmacogenomics: predicting efficacy and adverse drug reactions. Annu Rev Genomics Hum Genet 2014;15(1):349–70. Cross Ref link Pubmed link .
- 40 Warfarin pharmacogenetics: to genotype or not to genotype, that is the question. Clin Pharmacol Ther 2014;96(1):22–4. Cross Ref link Pubmed link , .
- 41 Thiopurine S‐methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996;58(4):8. , , , et al.
- 42 Molecular diagnosis of thiopurine S‐methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997;126(8):608–14. Cross Ref link Pubmed link , , , et al.
- 43 Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription. J Clin Pharm Ther 2007;32(2):187–95. Cross Ref link Pubmed link , , , et al.
- 44 Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. J Invest Dermatol 2008;128(8):1925–9. Cross Ref link Pubmed link , , , et al.
- 45 PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genom 2013;23(10):563–85. Cross Ref link , , , , .
- 46 HLA‐B*5701 screening for hypersensitivity to abacavir. N Eng J Med 2008;358(6):568–79. Cross Ref link , , , et al.
- 47 How were new medicines discovered? Nat Rev Drug Discov 2011;10(7):507–19. Cross Ref link Pubmed link , .
- 48 Directive 2010/63/EU of the European Parliament and of the Council. On the Protection of Animals used for Scientific Purposes, 22 September 2010. http://eur‐lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:en:PDF (last accessed January 2015).
- 49 Cytokine storm in a phase 1 trial of the anti‐CD28 monoclonal antibody TGN1412. N Eng J Med 2006;355(10): 1018–28. Cross Ref link , , , et al.
- 50 Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153(3):158–66. Cross Ref link Pubmed link , , .
- 51 Improving, and auditing, access to clinical trial results. BMJ 2014;348:g213. Cross Ref link Pubmed link , .
- 52 How frequently do the results from completed US clinical trials enter the public domain? – A statistical analysis of the ClinicalTrials.gov database. PLOS One 2014;9(7):e101826. Cross Ref link Pubmed link , .
- 53 Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012;344:d7292. Cross Ref link Pubmed link , , , , , .